BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
Símbolo de cotizaciónBGLC
Nombre de la empresaBioNexus Gene Lab Corp
Fecha de salida a bolsaMar 11, 2020
Director ejecutivoMr. Lee Su-Leng Tan
Número de empleados30
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 11
Dirección10-2 Tower B, Vertical Business Suite
CiudadKUALA LUMPUR
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísMalaysia
Código postal59200
Teléfono13072416898
Sitio Webhttps://www.bionexusgenelab.com/
Símbolo de cotizaciónBGLC
Fecha de salida a bolsaMar 11, 2020
Director ejecutivoMr. Lee Su-Leng Tan
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos